Vynleads (VYND) Return on Sales (2020 - 2023)

Vynleads (VYND) posted quarterly Return on Sales of 53.78% for Q1 2023, up 2.81% quarter-over-quarter from 55.33% in Q4 2022.

Vynleads (VYND) Return on Sales (2020 - 2023) Analysis & Trends

Vynleads (VYND) has reported Return on Sales for 4 consecutive years, with 53.78% the latest figure, recorded in Q1 2023.

In Q1 2023, Return on Sales changed N/A year-over-year to 53.78%; the TTM figure through Mar 2023 stood at 53.78% (changed N/A YoY), while the FY2022 annual figure was 55.84%, down 5141.0% from the prior year.
Return on Sales climbed to 53.78% in Q1 2023 per VYND's latest filing, from 55.33% in the prior quarter.
Across five years, Return on Sales topped out at 0.03% in Q1 2020 and bottomed at 56.32% in Q3 2022.
Historically, Return on Sales has averaged 16.08% across 4 years, with a median of 3.07% in 2021.
Annual changes were most pronounced in 2021 — Return on Sales tumbled 225 bps — and 2022, when it sank 5396 bps.
Vynleads' Return on Sales stood at 1.3% in 2020, then tumbled by 332 bps to 5.61% in 2021, then slumped by 886 bps to 55.33% in 2022, then rose by 3 bps to 53.78% in 2023.
Business Quant data shows VYND's Return on Sales at 53.78% in Q1 2023, 55.33% in Q4 2022, and 56.32% in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	0.00%
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	0.00%
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	0.00%
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	0.00%
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	0.00%
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	0.00%
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	0.00%
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	0.00%
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	0.00%
10	Vynleads	7.51 Mn	7.51 Mn	-2,028.00	-

Download Data